ArticleFrontiers in microbiology2022
Modification of Early Response of
Article in Frontiers in microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 13 citations in OpenAlex.
- Multiplexed LC-MS analysis reveals novel insights into grapevine defense mechanisms by expanding metabolome coverage.Metabolomics : Official journal of the Metabolomic Society · 2026Article
- Silver-selenium nanoparticles and selected chemical compounds significantly inhibit grapevine trunk disease pathogens.Pest management science · 2025Article
- Transcriptome profiling of symptomatic vs. asymptomatic grapevine plants reveals candidate genes for plant improvement against trunk diseases.BMC plant biology · 2025Article
- New Potential Biological Limiters of the Main Esca-Associated Fungi in Grapevine.Microorganisms · 2023Article
- Microbial Biological Control of Fungi Associated with Grapevine Trunk Diseases: A Review of Strain Diversity, Modes of Action, and Advantages and Limits of Current Strategies.Journal of fungi (Basel, Switzerland) · 2023Review
- The mycoparasiteFrontiers in plant science · 2023Article
- Preliminary Studies on the In Vitro Interactions Between the Secondary Metabolites Produced by Esca-Associated Fungi and EnologicalPlants (Basel, Switzerland) · 2022Article
- Comparative Transcriptomics Suggests Early Modifications by VintecFrontiers in microbiology · 2022Article
- Application of biostimulant products and biological control agents in sustainable viticulture: A review.Frontiers in plant science · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Esca disease is one of the most destructive grapevine trunk diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.